Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
Identifieur interne : 000234 ( Main/Corpus ); précédent : 000233; suivant : 000235Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
Auteurs : Bernard Ravina ; Karen Marder ; Hubert H. Fernandez ; Joseph H. Friedman ; William Mcdonald ; Diane Murphy ; Dag Aarsland ; Debra Babcock ; Jefferey Cummings ; Jean Endicott ; Stewart Factor ; Wendy Galpern ; Andrew Lees ; Laura Marsh ; Mark Stacy ; Katrina Gwinn-Hardy ; Valerie Voon ; Christopher GoetzSource :
- Movement Disorders [ 0885-3185 ] ; 2007-06-15.
English descriptors
- KwdEn :
Abstract
There are no standardized diagnostic criteria for psychosis associated with Parkinson's disease (PDPsy). As part of an NIH sponsored workshop, we reviewed the existing literature on PDPsy to provide criteria that distinguish PDPsy from other causes of psychosis. Based on these data, we propose provisional criteria for PDPsy in the style of the Diagnostic and Statistical Manual of Mental Disorders IV‐TR. PDPsy has a well‐characterized temporal and clinical profile of hallucinations and delusions, which is different than the pattern seen in other psychotic disorders such as substance induced psychosis or schizophrenia. PDPsy is associated with a poor prognosis of chronic psychosis, nursing home placement, and death. Medications used to treat Parkinson's disease (PD) contribute to PDPsy but may not be sufficient or necessary contributors to PDPsy. PDPsy is associated with Lewy bodies pathology, imbalances of monoaminergic neurotransmitters, and visuospatial processing deficits. These findings suggest that PDPsy may result from progression of the disease process underlying PD, rather than a comorbid psychiatric disorder or drug intoxication. PDPsy is not adequately described by existing criteria for psychotic disorders. We established provisional diagnostic criteria that define a constellation of clinical features not shared by other psychotic syndromes. The criteria are inclusive and contain descriptions of the full range of characteristic symptoms, chronology of onset, duration of symptoms, exclusionary diagnoses, and associated features such as dementia. These criteria require validation and may be refined, but form a starting point for studies of the epidemiology and pathophysiology of PDPsy, and are a potential indication for therapy development. © 2007 Movement Disorder Society
Url:
DOI: 10.1002/mds.21382
Links to Exploration step
ISTEX:699C23A6CC127EACD4EBBE922054FBFCF00F8EB0Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group</title><author><name sortKey="Ravina, Bernard" sort="Ravina, Bernard" uniqKey="Ravina B" first="Bernard" last="Ravina">Bernard Ravina</name><affiliation><mods:affiliation>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</mods:affiliation></affiliation></author><author><name sortKey="Marder, Karen" sort="Marder, Karen" uniqKey="Marder K" first="Karen" last="Marder">Karen Marder</name><affiliation><mods:affiliation>Department of Neurology, Columbia University New York Presbyterian, Medical Center College of Physicians and Surgeons, New York, New York, USA</mods:affiliation></affiliation></author><author><name sortKey="Fernandez, Hubert H" sort="Fernandez, Hubert H" uniqKey="Fernandez H" first="Hubert H." last="Fernandez">Hubert H. Fernandez</name><affiliation><mods:affiliation>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA</mods:affiliation></affiliation></author><author><name sortKey="Friedman, Joseph H" sort="Friedman, Joseph H" uniqKey="Friedman J" first="Joseph H." last="Friedman">Joseph H. Friedman</name><affiliation><mods:affiliation>Department of Clinical Neurosciences, Brown University, Warwick, Rhode Island, USA</mods:affiliation></affiliation></author><author><name sortKey="Mcdonald, William" sort="Mcdonald, William" uniqKey="Mcdonald W" first="William" last="Mcdonald">William Mcdonald</name><affiliation><mods:affiliation>Department of Psychiatry, Emory University, Atlanta, Georgia, USA</mods:affiliation></affiliation></author><author><name sortKey="Murphy, Diane" sort="Murphy, Diane" uniqKey="Murphy D" first="Diane" last="Murphy">Diane Murphy</name><affiliation><mods:affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation></author><author><name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name><affiliation><mods:affiliation>Norwegian Centre for Movement Disorders, Stavanger University Hospital and Institute of Clinical Medicine, University of Bergen, Norway, USA</mods:affiliation></affiliation></author><author><name sortKey="Babcock, Debra" sort="Babcock, Debra" uniqKey="Babcock D" first="Debra" last="Babcock">Debra Babcock</name><affiliation><mods:affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation></author><author><name sortKey="Cummings, Jefferey" sort="Cummings, Jefferey" uniqKey="Cummings J" first="Jefferey" last="Cummings">Jefferey Cummings</name><affiliation><mods:affiliation>Reed Neurological Research Center, University of California, Los Angeles, California, USA</mods:affiliation></affiliation></author><author><name sortKey="Endicott, Jean" sort="Endicott, Jean" uniqKey="Endicott J" first="Jean" last="Endicott">Jean Endicott</name><affiliation><mods:affiliation>Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA</mods:affiliation></affiliation></author><author><name sortKey="Factor, Stewart" sort="Factor, Stewart" uniqKey="Factor S" first="Stewart" last="Factor">Stewart Factor</name><affiliation><mods:affiliation>Department of Neurology, Emory University, Atlanta, Georgia, USA</mods:affiliation></affiliation></author><author><name sortKey="Galpern, Wendy" sort="Galpern, Wendy" uniqKey="Galpern W" first="Wendy" last="Galpern">Wendy Galpern</name><affiliation><mods:affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation></author><author><name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees</name><affiliation><mods:affiliation>Reta Lila Weston Institute of Neurological Studies, University College, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Marsh, Laura" sort="Marsh, Laura" uniqKey="Marsh L" first="Laura" last="Marsh">Laura Marsh</name><affiliation><mods:affiliation>Department of Psychiatry, Johns Hopkins University, Baltimore, Maryland, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA</mods:affiliation></affiliation></author><author><name sortKey="Stacy, Mark" sort="Stacy, Mark" uniqKey="Stacy M" first="Mark" last="Stacy">Mark Stacy</name><affiliation><mods:affiliation>Department of Neurology, Duke University, Durham, North Carolina, USA</mods:affiliation></affiliation></author><author><name sortKey="Gwinn Ardy, Katrina" sort="Gwinn Ardy, Katrina" uniqKey="Gwinn Ardy K" first="Katrina" last="Gwinn-Hardy">Katrina Gwinn-Hardy</name><affiliation><mods:affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation></author><author><name sortKey="Voon, Valerie" sort="Voon, Valerie" uniqKey="Voon V" first="Valerie" last="Voon">Valerie Voon</name><affiliation><mods:affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation></author><author><name sortKey="Goetz, Christopher" sort="Goetz, Christopher" uniqKey="Goetz C" first="Christopher" last="Goetz">Christopher Goetz</name><affiliation><mods:affiliation>Rush University Medical Center, Rush University Medical Center, Chicago, Illinois, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:699C23A6CC127EACD4EBBE922054FBFCF00F8EB0</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1002/mds.21382</idno><idno type="url">https://api.istex.fr/document/699C23A6CC127EACD4EBBE922054FBFCF00F8EB0/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000234</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group</title><author><name sortKey="Ravina, Bernard" sort="Ravina, Bernard" uniqKey="Ravina B" first="Bernard" last="Ravina">Bernard Ravina</name><affiliation><mods:affiliation>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</mods:affiliation></affiliation></author><author><name sortKey="Marder, Karen" sort="Marder, Karen" uniqKey="Marder K" first="Karen" last="Marder">Karen Marder</name><affiliation><mods:affiliation>Department of Neurology, Columbia University New York Presbyterian, Medical Center College of Physicians and Surgeons, New York, New York, USA</mods:affiliation></affiliation></author><author><name sortKey="Fernandez, Hubert H" sort="Fernandez, Hubert H" uniqKey="Fernandez H" first="Hubert H." last="Fernandez">Hubert H. Fernandez</name><affiliation><mods:affiliation>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA</mods:affiliation></affiliation></author><author><name sortKey="Friedman, Joseph H" sort="Friedman, Joseph H" uniqKey="Friedman J" first="Joseph H." last="Friedman">Joseph H. Friedman</name><affiliation><mods:affiliation>Department of Clinical Neurosciences, Brown University, Warwick, Rhode Island, USA</mods:affiliation></affiliation></author><author><name sortKey="Mcdonald, William" sort="Mcdonald, William" uniqKey="Mcdonald W" first="William" last="Mcdonald">William Mcdonald</name><affiliation><mods:affiliation>Department of Psychiatry, Emory University, Atlanta, Georgia, USA</mods:affiliation></affiliation></author><author><name sortKey="Murphy, Diane" sort="Murphy, Diane" uniqKey="Murphy D" first="Diane" last="Murphy">Diane Murphy</name><affiliation><mods:affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation></author><author><name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name><affiliation><mods:affiliation>Norwegian Centre for Movement Disorders, Stavanger University Hospital and Institute of Clinical Medicine, University of Bergen, Norway, USA</mods:affiliation></affiliation></author><author><name sortKey="Babcock, Debra" sort="Babcock, Debra" uniqKey="Babcock D" first="Debra" last="Babcock">Debra Babcock</name><affiliation><mods:affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation></author><author><name sortKey="Cummings, Jefferey" sort="Cummings, Jefferey" uniqKey="Cummings J" first="Jefferey" last="Cummings">Jefferey Cummings</name><affiliation><mods:affiliation>Reed Neurological Research Center, University of California, Los Angeles, California, USA</mods:affiliation></affiliation></author><author><name sortKey="Endicott, Jean" sort="Endicott, Jean" uniqKey="Endicott J" first="Jean" last="Endicott">Jean Endicott</name><affiliation><mods:affiliation>Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA</mods:affiliation></affiliation></author><author><name sortKey="Factor, Stewart" sort="Factor, Stewart" uniqKey="Factor S" first="Stewart" last="Factor">Stewart Factor</name><affiliation><mods:affiliation>Department of Neurology, Emory University, Atlanta, Georgia, USA</mods:affiliation></affiliation></author><author><name sortKey="Galpern, Wendy" sort="Galpern, Wendy" uniqKey="Galpern W" first="Wendy" last="Galpern">Wendy Galpern</name><affiliation><mods:affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation></author><author><name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees</name><affiliation><mods:affiliation>Reta Lila Weston Institute of Neurological Studies, University College, London, United Kingdom</mods:affiliation></affiliation></author><author><name sortKey="Marsh, Laura" sort="Marsh, Laura" uniqKey="Marsh L" first="Laura" last="Marsh">Laura Marsh</name><affiliation><mods:affiliation>Department of Psychiatry, Johns Hopkins University, Baltimore, Maryland, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA</mods:affiliation></affiliation></author><author><name sortKey="Stacy, Mark" sort="Stacy, Mark" uniqKey="Stacy M" first="Mark" last="Stacy">Mark Stacy</name><affiliation><mods:affiliation>Department of Neurology, Duke University, Durham, North Carolina, USA</mods:affiliation></affiliation></author><author><name sortKey="Gwinn Ardy, Katrina" sort="Gwinn Ardy, Katrina" uniqKey="Gwinn Ardy K" first="Katrina" last="Gwinn-Hardy">Katrina Gwinn-Hardy</name><affiliation><mods:affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation></author><author><name sortKey="Voon, Valerie" sort="Voon, Valerie" uniqKey="Voon V" first="Valerie" last="Voon">Valerie Voon</name><affiliation><mods:affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation></author><author><name sortKey="Goetz, Christopher" sort="Goetz, Christopher" uniqKey="Goetz C" first="Christopher" last="Goetz">Christopher Goetz</name><affiliation><mods:affiliation>Rush University Medical Center, Rush University Medical Center, Chicago, Illinois, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2007-06-15">2007-06-15</date><biblScope unit="volume">22</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="1061">1061</biblScope><biblScope unit="page" to="1068">1068</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">699C23A6CC127EACD4EBBE922054FBFCF00F8EB0</idno><idno type="DOI">10.1002/mds.21382</idno><idno type="ArticleID">MDS21382</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's</term><term>diagnosis</term><term>psychosis</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">There are no standardized diagnostic criteria for psychosis associated with Parkinson's disease (PDPsy). As part of an NIH sponsored workshop, we reviewed the existing literature on PDPsy to provide criteria that distinguish PDPsy from other causes of psychosis. Based on these data, we propose provisional criteria for PDPsy in the style of the Diagnostic and Statistical Manual of Mental Disorders IV‐TR. PDPsy has a well‐characterized temporal and clinical profile of hallucinations and delusions, which is different than the pattern seen in other psychotic disorders such as substance induced psychosis or schizophrenia. PDPsy is associated with a poor prognosis of chronic psychosis, nursing home placement, and death. Medications used to treat Parkinson's disease (PD) contribute to PDPsy but may not be sufficient or necessary contributors to PDPsy. PDPsy is associated with Lewy bodies pathology, imbalances of monoaminergic neurotransmitters, and visuospatial processing deficits. These findings suggest that PDPsy may result from progression of the disease process underlying PD, rather than a comorbid psychiatric disorder or drug intoxication. PDPsy is not adequately described by existing criteria for psychotic disorders. We established provisional diagnostic criteria that define a constellation of clinical features not shared by other psychotic syndromes. The criteria are inclusive and contain descriptions of the full range of characteristic symptoms, chronology of onset, duration of symptoms, exclusionary diagnoses, and associated features such as dementia. These criteria require validation and may be refined, but form a starting point for studies of the epidemiology and pathophysiology of PDPsy, and are a potential indication for therapy development. © 2007 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Bernard Ravina MD, MSCE</name><affiliations><json:string>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</json:string></affiliations></json:item><json:item><name>Karen Marder MD, MPH</name><affiliations><json:string>Department of Neurology, Columbia University New York Presbyterian, Medical Center College of Physicians and Surgeons, New York, New York, USA</json:string></affiliations></json:item><json:item><name>Hubert H. Fernandez MD</name><affiliations><json:string>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA</json:string></affiliations></json:item><json:item><name>Joseph H. Friedman MD</name><affiliations><json:string>Department of Clinical Neurosciences, Brown University, Warwick, Rhode Island, USA</json:string></affiliations></json:item><json:item><name>William McDonald MD</name><affiliations><json:string>Department of Psychiatry, Emory University, Atlanta, Georgia, USA</json:string></affiliations></json:item><json:item><name>Diane Murphy PhD</name><affiliations><json:string>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</json:string></affiliations></json:item><json:item><name>Dag Aarsland MD</name><affiliations><json:string>Norwegian Centre for Movement Disorders, Stavanger University Hospital and Institute of Clinical Medicine, University of Bergen, Norway, USA</json:string></affiliations></json:item><json:item><name>Debra Babcock MD, PhD</name><affiliations><json:string>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</json:string></affiliations></json:item><json:item><name>Jefferey Cummings MD</name><affiliations><json:string>Reed Neurological Research Center, University of California, Los Angeles, California, USA</json:string></affiliations></json:item><json:item><name>Jean Endicott PhD</name><affiliations><json:string>Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA</json:string></affiliations></json:item><json:item><name>Stewart Factor MD</name><affiliations><json:string>Department of Neurology, Emory University, Atlanta, Georgia, USA</json:string></affiliations></json:item><json:item><name>Wendy Galpern MD, PhD</name><affiliations><json:string>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</json:string></affiliations></json:item><json:item><name>Andrew Lees MD</name><affiliations><json:string>Reta Lila Weston Institute of Neurological Studies, University College, London, United Kingdom</json:string></affiliations></json:item><json:item><name>Laura Marsh MD</name><affiliations><json:string>Department of Psychiatry, Johns Hopkins University, Baltimore, Maryland, USA</json:string><json:string>Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA</json:string></affiliations></json:item><json:item><name>Mark Stacy MD</name><affiliations><json:string>Department of Neurology, Duke University, Durham, North Carolina, USA</json:string></affiliations></json:item><json:item><name>Katrina Gwinn‐Hardy MD</name><affiliations><json:string>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</json:string></affiliations></json:item><json:item><name>Valerie Voon MD</name><affiliations><json:string>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</json:string></affiliations></json:item><json:item><name>Christopher Goetz MD</name><affiliations><json:string>Rush University Medical Center, Rush University Medical Center, Chicago, Illinois, USA</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>psychosis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>diagnosis</value></json:item></subject><articleId><json:string>MDS21382</json:string></articleId><language><json:string>eng</json:string></language><abstract>There are no standardized diagnostic criteria for psychosis associated with Parkinson's disease (PDPsy). As part of an NIH sponsored workshop, we reviewed the existing literature on PDPsy to provide criteria that distinguish PDPsy from other causes of psychosis. Based on these data, we propose provisional criteria for PDPsy in the style of the Diagnostic and Statistical Manual of Mental Disorders IV‐TR. PDPsy has a well‐characterized temporal and clinical profile of hallucinations and delusions, which is different than the pattern seen in other psychotic disorders such as substance induced psychosis or schizophrenia. PDPsy is associated with a poor prognosis of chronic psychosis, nursing home placement, and death. Medications used to treat Parkinson's disease (PD) contribute to PDPsy but may not be sufficient or necessary contributors to PDPsy. PDPsy is associated with Lewy bodies pathology, imbalances of monoaminergic neurotransmitters, and visuospatial processing deficits. These findings suggest that PDPsy may result from progression of the disease process underlying PD, rather than a comorbid psychiatric disorder or drug intoxication. PDPsy is not adequately described by existing criteria for psychotic disorders. We established provisional diagnostic criteria that define a constellation of clinical features not shared by other psychotic syndromes. The criteria are inclusive and contain descriptions of the full range of characteristic symptoms, chronology of onset, duration of symptoms, exclusionary diagnoses, and associated features such as dementia. These criteria require validation and may be refined, but form a starting point for studies of the epidemiology and pathophysiology of PDPsy, and are a potential indication for therapy development. © 2007 Movement Disorder Society</abstract><qualityIndicators><score>8</score><pdfVersion>1.3</pdfVersion><pdfPageSize>594 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>3</keywordCount><abstractCharCount>1810</abstractCharCount><pdfWordCount>5406</pdfWordCount><pdfCharCount>36979</pdfCharCount><pdfPageCount>8</pdfPageCount><abstractWordCount>257</abstractWordCount></qualityIndicators><title>Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group</title><genre><json:string>article</json:string></genre><host><volume>22</volume><publisherId><json:string>MDS</json:string></publisherId><pages><total>8</total><last>1068</last><first>1061</first></pages><issn><json:string>0885-3185</json:string></issn><issue>8</issue><subject><json:item><value>Viewpoint</value></json:item></subject><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8257</json:string></eissn><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2007</publicationDate><copyrightDate>2007</copyrightDate><doi><json:string>10.1002/mds.21382</json:string></doi><id>699C23A6CC127EACD4EBBE922054FBFCF00F8EB0</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/699C23A6CC127EACD4EBBE922054FBFCF00F8EB0/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/699C23A6CC127EACD4EBBE922054FBFCF00F8EB0/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/699C23A6CC127EACD4EBBE922054FBFCF00F8EB0/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>WILEY</p></availability><date>2007</date></publicationStmt><notesStmt><note>National Institutes of Health (NINDS NIMH)</note><note>Acadia Pharmaceuticals</note><note>Ovation Pharmaceuticals</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group</title><author><persName><forename type="first">Bernard</forename><surname>Ravina</surname></persName><roleName type="degree">MD, MSCE</roleName><note type="correspondence"><p>Correspondence: 1351 Mt. Hope Ave., Suite 223, Rochester, NY 14620</p></note><affiliation>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</affiliation></author><author><persName><forename type="first">Karen</forename><surname>Marder</surname></persName><roleName type="degree">MD, MPH</roleName><affiliation>Department of Neurology, Columbia University New York Presbyterian, Medical Center College of Physicians and Surgeons, New York, New York, USA</affiliation></author><author><persName><forename type="first">Hubert H.</forename><surname>Fernandez</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA</affiliation></author><author><persName><forename type="first">Joseph H.</forename><surname>Friedman</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Clinical Neurosciences, Brown University, Warwick, Rhode Island, USA</affiliation></author><author><persName><forename type="first">William</forename><surname>McDonald</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Psychiatry, Emory University, Atlanta, Georgia, USA</affiliation></author><author><persName><forename type="first">Diane</forename><surname>Murphy</surname></persName><roleName type="degree">PhD</roleName><affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</affiliation></author><author><persName><forename type="first">Dag</forename><surname>Aarsland</surname></persName><roleName type="degree">MD</roleName><affiliation>Norwegian Centre for Movement Disorders, Stavanger University Hospital and Institute of Clinical Medicine, University of Bergen, Norway, USA</affiliation></author><author><persName><forename type="first">Debra</forename><surname>Babcock</surname></persName><roleName type="degree">MD, PhD</roleName><affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</affiliation></author><author><persName><forename type="first">Jefferey</forename><surname>Cummings</surname></persName><roleName type="degree">MD</roleName><affiliation>Reed Neurological Research Center, University of California, Los Angeles, California, USA</affiliation></author><author><persName><forename type="first">Jean</forename><surname>Endicott</surname></persName><roleName type="degree">PhD</roleName><affiliation>Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA</affiliation></author><author><persName><forename type="first">Stewart</forename><surname>Factor</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Neurology, Emory University, Atlanta, Georgia, USA</affiliation></author><author><persName><forename type="first">Wendy</forename><surname>Galpern</surname></persName><roleName type="degree">MD, PhD</roleName><affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</affiliation></author><author><persName><forename type="first">Andrew</forename><surname>Lees</surname></persName><roleName type="degree">MD</roleName><affiliation>Reta Lila Weston Institute of Neurological Studies, University College, London, United Kingdom</affiliation></author><author><persName><forename type="first">Laura</forename><surname>Marsh</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Psychiatry, Johns Hopkins University, Baltimore, Maryland, USA</affiliation><affiliation>Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA</affiliation></author><author><persName><forename type="first">Mark</forename><surname>Stacy</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Neurology, Duke University, Durham, North Carolina, USA</affiliation></author><author><persName><forename type="first">Katrina</forename><surname>Gwinn‐Hardy</surname></persName><roleName type="degree">MD</roleName><affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</affiliation></author><author><persName><forename type="first">Valerie</forename><surname>Voon</surname></persName><roleName type="degree">MD</roleName><affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</affiliation></author><author><persName><forename type="first">Christopher</forename><surname>Goetz</surname></persName><roleName type="degree">MD</roleName><affiliation>Rush University Medical Center, Rush University Medical Center, Chicago, Illinois, USA</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2007-06-15"></date><biblScope unit="volume">22</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="1061">1061</biblScope><biblScope unit="page" to="1068">1068</biblScope></imprint></monogr><idno type="istex">699C23A6CC127EACD4EBBE922054FBFCF00F8EB0</idno><idno type="DOI">10.1002/mds.21382</idno><idno type="ArticleID">MDS21382</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2007</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>There are no standardized diagnostic criteria for psychosis associated with Parkinson's disease (PDPsy). As part of an NIH sponsored workshop, we reviewed the existing literature on PDPsy to provide criteria that distinguish PDPsy from other causes of psychosis. Based on these data, we propose provisional criteria for PDPsy in the style of the Diagnostic and Statistical Manual of Mental Disorders IV‐TR. PDPsy has a well‐characterized temporal and clinical profile of hallucinations and delusions, which is different than the pattern seen in other psychotic disorders such as substance induced psychosis or schizophrenia. PDPsy is associated with a poor prognosis of chronic psychosis, nursing home placement, and death. Medications used to treat Parkinson's disease (PD) contribute to PDPsy but may not be sufficient or necessary contributors to PDPsy. PDPsy is associated with Lewy bodies pathology, imbalances of monoaminergic neurotransmitters, and visuospatial processing deficits. These findings suggest that PDPsy may result from progression of the disease process underlying PD, rather than a comorbid psychiatric disorder or drug intoxication. PDPsy is not adequately described by existing criteria for psychotic disorders. We established provisional diagnostic criteria that define a constellation of clinical features not shared by other psychotic syndromes. The criteria are inclusive and contain descriptions of the full range of characteristic symptoms, chronology of onset, duration of symptoms, exclusionary diagnoses, and associated features such as dementia. These criteria require validation and may be refined, but form a starting point for studies of the epidemiology and pathophysiology of PDPsy, and are a potential indication for therapy development. © 2007 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Parkinson's</term></item><item><term>psychosis</term></item><item><term>diagnosis</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article category</head><item><term>Viewpoint</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2006-10-24">Received</change><change when="2006-12-04">Registration</change><change when="2007-06-15">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/699C23A6CC127EACD4EBBE922054FBFCF00F8EB0/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="80"><doi origin="wiley" registered="yes">10.1002/mds.v22:8</doi><numberingGroup><numbering type="journalVolume" number="22">22</numbering><numbering type="journalIssue">8</numbering></numberingGroup><coverDate startDate="2007-06-15">15 June 2007</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="10" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.21382</doi><idGroup><id type="unit" value="MDS21382"></id></idGroup><countGroup><count type="pageTotal" number="8"></count></countGroup><titleGroup><title type="articleCategory">Viewpoint</title><title type="tocHeading1">Viewpoint</title></titleGroup><copyright ownership="thirdParty">Copyright © 2007 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2006-10-24"></event><event type="manuscriptAccepted" date="2006-12-04"></event><event type="firstOnline" date="2007-01-31"></event><event type="publishedOnlineFinalForm" date="2007-06-19"></event><event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2007-01-31"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4.7 mode:FullText source:FullText result:FullText" date="2011-02-24"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">1061</numbering><numbering type="pageLast">1068</numbering></numberingGroup><correspondenceTo>1351 Mt. Hope Ave., Suite 223, Rochester, NY 14620</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS21382.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="1"></count><count type="referenceTotal" number="61"></count><count type="wordTotal" number="5990"></count></countGroup><titleGroup><title type="main" xml:lang="en">Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group</title><title type="short" xml:lang="en">Diagnostic Criteria For Psychosis in PD</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Bernard</givenNames><familyName>Ravina</familyName><degrees>MD, MSCE</degrees></personName><contactDetails><email>Bernard.ravina@ctcc.rochester.edu</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Karen</givenNames><familyName>Marder</familyName><degrees>MD, MPH</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Hubert H.</givenNames><familyName>Fernandez</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af4"><personName><givenNames>Joseph H.</givenNames><familyName>Friedman</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af5"><personName><givenNames>William</givenNames><familyName>McDonald</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au6" creatorRole="author" affiliationRef="#af6"><personName><givenNames>Diane</givenNames><familyName>Murphy</familyName><degrees>PhD</degrees></personName></creator><creator xml:id="au7" creatorRole="author" affiliationRef="#af7"><personName><givenNames>Dag</givenNames><familyName>Aarsland</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au8" creatorRole="author" affiliationRef="#af6"><personName><givenNames>Debra</givenNames><familyName>Babcock</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au9" creatorRole="author" affiliationRef="#af8"><personName><givenNames>Jefferey</givenNames><familyName>Cummings</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au10" creatorRole="author" affiliationRef="#af9"><personName><givenNames>Jean</givenNames><familyName>Endicott</familyName><degrees>PhD</degrees></personName></creator><creator xml:id="au11" creatorRole="author" affiliationRef="#af10"><personName><givenNames>Stewart</givenNames><familyName>Factor</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au12" creatorRole="author" affiliationRef="#af6"><personName><givenNames>Wendy</givenNames><familyName>Galpern</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au13" creatorRole="author" affiliationRef="#af11"><personName><givenNames>Andrew</givenNames><familyName>Lees</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au14" creatorRole="author" affiliationRef="#af12 #af13"><personName><givenNames>Laura</givenNames><familyName>Marsh</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au15" creatorRole="author" affiliationRef="#af14"><personName><givenNames>Mark</givenNames><familyName>Stacy</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au16" creatorRole="author" affiliationRef="#af6"><personName><givenNames>Katrina</givenNames><familyName>Gwinn‐Hardy</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au17" creatorRole="author" affiliationRef="#af6"><personName><givenNames>Valerie</givenNames><familyName>Voon</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au18" creatorRole="author" affiliationRef="#af15"><personName><givenNames>Christopher</givenNames><familyName>Goetz</familyName><degrees>MD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurology, Columbia University New York Presbyterian, Medical Center College of Physicians and Surgeons, New York, New York, USA</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA</unparsedAffiliation></affiliation><affiliation xml:id="af4" countryCode="US" type="organization"><unparsedAffiliation>Department of Clinical Neurosciences, Brown University, Warwick, Rhode Island, USA</unparsedAffiliation></affiliation><affiliation xml:id="af5" countryCode="US" type="organization"><unparsedAffiliation>Department of Psychiatry, Emory University, Atlanta, Georgia, USA</unparsedAffiliation></affiliation><affiliation xml:id="af6" countryCode="US" type="organization"><unparsedAffiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</unparsedAffiliation></affiliation><affiliation xml:id="af7" countryCode="US" type="organization"><unparsedAffiliation>Norwegian Centre for Movement Disorders, Stavanger University Hospital and Institute of Clinical Medicine, University of Bergen, Norway, USA</unparsedAffiliation></affiliation><affiliation xml:id="af8" countryCode="US" type="organization"><unparsedAffiliation>Reed Neurological Research Center, University of California, Los Angeles, California, USA</unparsedAffiliation></affiliation><affiliation xml:id="af9" countryCode="US" type="organization"><unparsedAffiliation>Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA</unparsedAffiliation></affiliation><affiliation xml:id="af10" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurology, Emory University, Atlanta, Georgia, USA</unparsedAffiliation></affiliation><affiliation xml:id="af11" countryCode="GB" type="organization"><unparsedAffiliation>Reta Lila Weston Institute of Neurological Studies, University College, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af12" countryCode="US" type="organization"><unparsedAffiliation>Department of Psychiatry, Johns Hopkins University, Baltimore, Maryland, USA</unparsedAffiliation></affiliation><affiliation xml:id="af13" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA</unparsedAffiliation></affiliation><affiliation xml:id="af14" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurology, Duke University, Durham, North Carolina, USA</unparsedAffiliation></affiliation><affiliation xml:id="af15" countryCode="US" type="organization"><unparsedAffiliation>Rush University Medical Center, Rush University Medical Center, Chicago, Illinois, USA</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Parkinson's</keyword><keyword xml:id="kwd2">psychosis</keyword><keyword xml:id="kwd3">diagnosis</keyword></keywordGroup><fundingInfo><fundingAgency>National Institutes of Health (NINDS NIMH)</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Acadia Pharmaceuticals</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Ovation Pharmaceuticals</fundingAgency></fundingInfo><supportingInformation><p> This article is part of the journal's CME program. The CME form can be found on page 1214 and is available online at <url href="http://www.movementdisorders.org/education/activities.html"> http://www.movementdisorders.org/education/activities.html </url> . </p></supportingInformation><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>There are no standardized diagnostic criteria for psychosis associated with Parkinson's disease (PDPsy). As part of an NIH sponsored workshop, we reviewed the existing literature on PDPsy to provide criteria that distinguish PDPsy from other causes of psychosis. Based on these data, we propose provisional criteria for PDPsy in the style of the Diagnostic and Statistical Manual of Mental Disorders IV‐TR. PDPsy has a well‐characterized temporal and clinical profile of hallucinations and delusions, which is different than the pattern seen in other psychotic disorders such as substance induced psychosis or schizophrenia. PDPsy is associated with a poor prognosis of chronic psychosis, nursing home placement, and death. Medications used to treat Parkinson's disease (PD) contribute to PDPsy but may not be sufficient or necessary contributors to PDPsy. PDPsy is associated with Lewy bodies pathology, imbalances of monoaminergic neurotransmitters, and visuospatial processing deficits. These findings suggest that PDPsy may result from progression of the disease process underlying PD, rather than a comorbid psychiatric disorder or drug intoxication. PDPsy is not adequately described by existing criteria for psychotic disorders. We established provisional diagnostic criteria that define a constellation of clinical features not shared by other psychotic syndromes. The criteria are inclusive and contain descriptions of the full range of characteristic symptoms, chronology of onset, duration of symptoms, exclusionary diagnoses, and associated features such as dementia. These criteria require validation and may be refined, but form a starting point for studies of the epidemiology and pathophysiology of PDPsy, and are a potential indication for therapy development. © 2007 Movement Disorder Society</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Diagnostic Criteria For Psychosis in PD</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group</title></titleInfo><name type="personal"><namePart type="given">Bernard</namePart><namePart type="family">Ravina</namePart><namePart type="termsOfAddress">MD, MSCE</namePart><affiliation>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</affiliation><description>Correspondence: 1351 Mt. Hope Ave., Suite 223, Rochester, NY 14620</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Karen</namePart><namePart type="family">Marder</namePart><namePart type="termsOfAddress">MD, MPH</namePart><affiliation>Department of Neurology, Columbia University New York Presbyterian, Medical Center College of Physicians and Surgeons, New York, New York, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Hubert H.</namePart><namePart type="family">Fernandez</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Joseph H.</namePart><namePart type="family">Friedman</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Clinical Neurosciences, Brown University, Warwick, Rhode Island, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">William</namePart><namePart type="family">McDonald</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Psychiatry, Emory University, Atlanta, Georgia, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Diane</namePart><namePart type="family">Murphy</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Dag</namePart><namePart type="family">Aarsland</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Norwegian Centre for Movement Disorders, Stavanger University Hospital and Institute of Clinical Medicine, University of Bergen, Norway, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Debra</namePart><namePart type="family">Babcock</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Jefferey</namePart><namePart type="family">Cummings</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Reed Neurological Research Center, University of California, Los Angeles, California, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Jean</namePart><namePart type="family">Endicott</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Stewart</namePart><namePart type="family">Factor</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Emory University, Atlanta, Georgia, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Wendy</namePart><namePart type="family">Galpern</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Andrew</namePart><namePart type="family">Lees</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Reta Lila Weston Institute of Neurological Studies, University College, London, United Kingdom</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Laura</namePart><namePart type="family">Marsh</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Psychiatry, Johns Hopkins University, Baltimore, Maryland, USA</affiliation><affiliation>Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Mark</namePart><namePart type="family">Stacy</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Duke University, Durham, North Carolina, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Katrina</namePart><namePart type="family">Gwinn‐Hardy</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Valerie</namePart><namePart type="family">Voon</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, Maryland, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Christopher</namePart><namePart type="family">Goetz</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Rush University Medical Center, Rush University Medical Center, Chicago, Illinois, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2007-06-15</dateIssued><dateCaptured encoding="w3cdtf">2006-10-24</dateCaptured><dateValid encoding="w3cdtf">2006-12-04</dateValid><copyrightDate encoding="w3cdtf">2007</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">1</extent><extent unit="references">61</extent><extent unit="words">5990</extent></physicalDescription><abstract lang="en">There are no standardized diagnostic criteria for psychosis associated with Parkinson's disease (PDPsy). As part of an NIH sponsored workshop, we reviewed the existing literature on PDPsy to provide criteria that distinguish PDPsy from other causes of psychosis. Based on these data, we propose provisional criteria for PDPsy in the style of the Diagnostic and Statistical Manual of Mental Disorders IV‐TR. PDPsy has a well‐characterized temporal and clinical profile of hallucinations and delusions, which is different than the pattern seen in other psychotic disorders such as substance induced psychosis or schizophrenia. PDPsy is associated with a poor prognosis of chronic psychosis, nursing home placement, and death. Medications used to treat Parkinson's disease (PD) contribute to PDPsy but may not be sufficient or necessary contributors to PDPsy. PDPsy is associated with Lewy bodies pathology, imbalances of monoaminergic neurotransmitters, and visuospatial processing deficits. These findings suggest that PDPsy may result from progression of the disease process underlying PD, rather than a comorbid psychiatric disorder or drug intoxication. PDPsy is not adequately described by existing criteria for psychotic disorders. We established provisional diagnostic criteria that define a constellation of clinical features not shared by other psychotic syndromes. The criteria are inclusive and contain descriptions of the full range of characteristic symptoms, chronology of onset, duration of symptoms, exclusionary diagnoses, and associated features such as dementia. These criteria require validation and may be refined, but form a starting point for studies of the epidemiology and pathophysiology of PDPsy, and are a potential indication for therapy development. © 2007 Movement Disorder Society</abstract><note type="funding">National Institutes of Health (NINDS NIMH)</note><note type="funding">Acadia Pharmaceuticals</note><note type="funding">Ovation Pharmaceuticals</note><subject lang="en"><genre>Keywords</genre><topic>Parkinson's</topic><topic>psychosis</topic><topic>diagnosis</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><genre type="Journal">journal</genre><note type="content"> This article is part of the journal's CME program. The CME form can be found on page 1214 and is available online at http://www.movementdisorders.org/education/activities.html .</note><subject><genre>article category</genre><topic>Viewpoint</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><detail type="issue"><caption>no.</caption><number>8</number></detail><extent unit="pages"><start>1061</start><end>1068</end><total>8</total></extent></part></relatedItem><identifier type="istex">699C23A6CC127EACD4EBBE922054FBFCF00F8EB0</identifier><identifier type="DOI">10.1002/mds.21382</identifier><identifier type="ArticleID">MDS21382</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2007 Movement Disorder Society</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000234 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000234 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:699C23A6CC127EACD4EBBE922054FBFCF00F8EB0
|texte= Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
}}
| This area was generated with Dilib version V0.6.23. |  |